Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy.

Discovery medicine - 1 Dec 2013

Polk Brooke I, Becker Mara L

Abstract excerpt

Investigating the effect of genotype on drug response in children is an evolving field, with many challenges, but there is great potential to optimize safe and effective use of drugs in children. An exponential increase in available medications for use in children with rheumatic disease has opened seemingly endless genotype/phenotype relationships to explore, but challenges inherent in studying rare diseases and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antirheumatic Agents
Share to Azathioprine
Share to Biological Products

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Methotrexate

Share to Mycophenolic Acid

Share to Pharmacogenetics

Share to Precision Medicine

Share to Rheumatic Diseases

Source

Identifiers

PMID: 24333406

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy.PMID 24333406Read ↗

In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?Semantic proximity Read ↗

Personalized therapies in pediatric inflammatory and autoimmune diseases.Semantic proximity Read ↗

Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.Semantic proximity Read ↗

Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyondSemantic proximity Read ↗

Clinically relevant pharmacogenomic testing in pediatric practice.Semantic proximity Read ↗

Genomics and epigenomics in rheumatic diseases: what do they provide in terms of diagnosis and disease management?Semantic proximity Read ↗

Identifying genomic and developmental causes of adverse drug reactions in children.Semantic proximity Read ↗

The genetics of juvenile idiopathic arthritis: current understanding and future prospects.Semantic proximity Read ↗

Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.Semantic proximity Read ↗

Epidemiology of the rheumatic diseases of childhood.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics in rheumatology.Semantic proximity Read ↗

Pharmacogenomics of Anti-Inflammatory Therapy: Toward Personalized Use of Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, and BiologicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.